Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting
- 27 November 2000
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 36 (7) , 2168-2173
- https://doi.org/10.1016/s0735-1097(00)01014-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Interlesion Dependence of the Risk for Restenosis in Patients With Coronary Stent Placement in Multiple LesionsCirculation, 1998
- An Analysis of Linkage Disequilibrium in the Interleukin-1 Gene Cluster, Using a Novel Grouping Method for Multiallelic MarkersAmerican Journal of Human Genetics, 1998
- INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in BiologyAnnual Review of Immunology, 1998
- Coronary Angioplasty Results in Leukocyte and Platelet Activation With Adhesion Molecule Expression: Evidence of Inflammatory Responses in Coronary AngioplastyJournal of the American College of Cardiology, 1997
- Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphismClinical and Experimental Immunology, 1995
- A Physical Map of the Region Encompassing the Human Interleukin-1α, Interleukin-1β, and Interleukin-1 Receptor Antagonist GenesGenomics, 1994
- Effect of interleukin-1 receptor antagonist on vascular smooth muscle cell proliferationAtherosclerosis, 1993
- Interleukin 1: the first interleukinImmunology Today, 1990
- Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.Journal of Clinical Investigation, 1988